Translational Research: Lead Optimization
Lead optimization is the process of generating a pre-therapeutic lead candidate by improving the properties of small molecules or non-viral biologics for which positive and negative attributes have been identified and candidates are tractable to modification. Examples of properties to be improved may be potency, efficacy, selectivity, or bioavailability. This process typically involves the generation and testing of multiple new agents in order to gain a scientific understanding of how variations in lead candidates effect these properties. It is expected that lead optimization will involve assessment of efficacy in animal models and/or ex vivo human samples.
Target AssayScreeningHits and
HitHit to LeadLead Series
NIDDK-Specific Funding Opportunities
- PAR-16-121, Early-Stage Preclinical Validation of Therapeutic Leads for Diseases of Interest to the NIDDK (R01)
- PA-17-131, Lead Optimization and Pre-Clinical Development of Therapeutic Candidates for Diseases of Interest to the NIDDK (R41/R42, Small Business Technology Transfer Research Grant)
- PA-17-130, Lead Optimization and Pre-Clinical Development of Therapeutic Candidates for Diseases of Interest to the NIDDK (R43/R44, Small Business Innovation Research Grant)
- Academic Drug Discovery Consortium
- NIH Molecular Libraries and Imaging
- NCATS TRND
- Medicinal Chemical Facilities
- NIDDK Small Business Programs
For additional information, please contact Dr. Aaron Pawlyk.